Skip to main content
. Author manuscript; available in PMC: 2022 Jan 10.
Published in final edited form as: Gynecol Oncol. 2011 Oct 26;124(1):119–124. doi: 10.1016/j.ygyno.2011.09.020

Figure 2.

Figure 2.

Increased expression of phosphorylated BAD (pBAD) decreases cisplatin sensitivity. Depletion of PP2C by siRNA in the endometrial cell lines Ishikawa (A) and HEC-1-A (B) resulted in increased expression of pBAD-serine-155 and decreased sensitivity to cisplatin-induced cell growth arrest.